Invention Grant
- Patent Title: Mitochondrial protease OMA1 as a marker for breast cancer
-
Application No.: US16476961Application Date: 2018-01-12
-
Publication No.: US12050218B2Publication Date: 2024-07-30
- Inventor: Srivatsan Kidambi , Oleh Khalimonchuk
- Applicant: NUtech Ventures
- Applicant Address: US NE Lincoln
- Assignee: NUtech Ventures
- Current Assignee: NUtech Ventures
- Current Assignee Address: US NE Lincoln
- Agency: Sandberg Phoenix & von Gontard, PC
- Agent Jeannie M. Boettler
- International Application: PCT/US2018/013497 2018.01.12
- International Announcement: WO2018/132662A 2018.07.19
- Date entered country: 2019-07-10
- Main IPC: G01N31/00
- IPC: G01N31/00 ; C07K16/30 ; C12N9/64 ; G01N33/53 ; G01N33/574
Abstract:
The use of mitochondrial protease OMA1 as a theranostic marker for breast cancer, tumor progression, metastatis and drug responsiveness is disclosed herein.
Information query
